While reprogrammed cellular metabolism is a widely accepted hallmark of cancer (Hanahan and Weinberg, 2011), our study adds to this by reporting for the first time that ZEB1 significantly enhances glycolysis in CRC cells. Here, ZEB1 is linked to cancer.